SLC2A3 and attention deficit-hyperactivity disorder: In addition, SLC2A3 was identified as a potential risk gene or to display aberrant expression in several psychiatric disorders such as schizophrenia (Kuzman et al., 2009; De Silva, 2011; Sullivan et al., 2018), dyslexia (Roeske et al., 2011; Skeide et al., 2015), affective disorders (Yang et al., 2009), autism (Zhao et al., 2010; O’Roak et al., 2012; Dai et al., 2017) and attention-deficit/hyperactivity disorder (ADHD; Lesch et al., 2011; Merker et al., 2017).